智通财经APP获悉，启明医疗-B(02500)涨超14%，截至发稿，涨14.01%，报2.93港元，成交额1077.73万港元。
消息面上，启明医疗宣布，Cardiovalve经导管三尖瓣置换（TTVR）创新器械确证性临床研究已成功完成全部150例患者临床入组。这是Cardiovalve在三尖瓣反流治疗领域的又一次重大研发进展，标志着其在获取CE Mark的道路上迈出了关键里程碑。此外，TARGET研究的中期结果将于今年的伦敦心脏瓣膜介入治疗会议（PCR London Valves 2025）上正式发布。
公司表示，未来将持续推进包括Cardiovalve等多款自主研发的创新产品在全球范围内的临床研究、注册申报和商业化布局，致力于早日实现“四瓣一体”结构性心脏瓣膜产品的完整布局，为全球更多患者提供领先的瓣膜疾病解决方案，并进一步深化公司的国际化发展战略。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.